3 Injectable Sulfas 500ml

3 Injectable Sulfas 500ml is an advanced, high-potency veterinary broad-spectrum sulfonamide combination formulation meticulously engineered to combat severe bacterial infections, control systemic microbial proliferation, and facilitate comprehensive clinical recovery in large animals and equines operating under rigorous professional veterinary care. Combining a precise, synergistic blend of three distinct sulfonamide antibacterial agents within a specialized, sterile injectable vehicle, this professional-grade therapeutic preparation delivers targeted antimicrobial support designed specifically for animals confronting acute respiratory infections, gastrointestinal pathogens, urogenital sepsis, or complex systemic disease challenges. Because of its potent pharmacological profile and profound physiological impact, the administration of 3 Injectable Sulfas requires precise clinical diagnosis, individualized treatment planning, and strict adherence to professional veterinary guidelines.

What Is 3 Injectable Sulfas 500ml?

3 Injectable Sulfas 500ml is a specialized veterinary therapeutic compound formulated for parenteral administration under professional clinical supervision.

PHARMACOKINETICS

When administered parenterally or orally, three Sulfas exhibit excellent absorption. They enter the bloodstream, distribute throughout the body, and bind to plasma albumin. They diffuse rapidly, reaching high concentrations in extraplasmatic fluids, allowing the elimination of bacterial infections, most of which are extravascular. They also diffuse easily into the fetus and fetal membranes, and are found in lower concentrations in the central nervous system, bones, and adipose tissue. They are metabolized in the liver and excreted by glomerular filtration and tubular secretion in the kidneys. Smaller amounts are eliminated in feces, bile, pancreatic juice, gastric juice, saliva, and milk.

IMPORTANCE

The importance of 3 SULFAS lies in the fact that the combination of SULFAS it contains provides greater solubility, better absorption, less renal toxic effect and a broader spectrum of antibacterial action against gram-positive and gram-negative bacteria, which cause digestive, respiratory, genitourinary, mammary gland, locomotor system and septicemic diseases in cattle, horses, sheep, pigs, birds and dogs.

INDICATIONS

3 SULFAs are indicated for the treatment of infections of the respiratory tract (pneumonia, bronchopneumonia, etc.), the gastrointestinal tract (colibacillosis), the upper and lower urinary tract, the genital tract (septic metritis, placental retention), the locomotor system (gabarro), the mammary gland (acute and chronic mastitis) and other infections that affect cattle, sheep, goats, pigs (hemorrhagic septicemia, necrotic enteritis), canines (pneumonia, bacillary diarrhea and complications of canine distemper) and birds (coccidiosis, salmonellosis and fowl cholera).

ROUTE OF ADMINISTRATION AND DOSAGE:

• Intravenous: In cattle, horses, sheep, goats and dogs.
• Intramuscular: In pigs
• Oral in drinking water: In birds

The dosage depends on the particular case, however, in general terms the recommended dosage is:

• Equines and Bovines: 50 mL of 3 SULFAs per 100 kg intravenously (100 mg/kg of weight).
• Pigs, Sheep and Goats: 7 mL of 3 SULFAS’ per 10 kg (140 mg/kg weight).
• In Dogs and Cats: 3.5 to 7 mL of 3 SULFAS per 10 kg via slow intravenous route (70 – 140 mg per kg of weight).
• In birds, the dose will depend on the route of administration: Intramuscular: 0.5 mL of 3 SULFAS per 1 kg. Drinking water: 5 mL of 3 SULFAS per liter of drinking water for 2 to 3 days of treatment, followed by a 2 to 3-day break, and then repeating the administration every 2 to 3 more days. Respiratory problems: 100 mg/kg. Digestive problems: 50 mg/kg of body weight.

CONTRAINDICATIONS

It should not be used in animals that show liver or kidney damage, blood dyscrasias, or a history of hypersensitivity to sulfonamides.

Do not use in horses intended for human consumption. Due to its potential for urine crystallization, it is advisable to avoid use in dogs with a history of urolithiasis or at high risk of developing urolithiasis.

ADVERSE EFFECTS

In dogs, dry keratoconjunctivitis (which may not be reversible), acute neutrophilic hepatitis, anorexia, diarrhea, fever, hemolytic anemia, urticaria, polyatritis, facial swelling, polydipsia, polyuria, and cholestasis may occur . Potentiated sulfonamides may cause hypothyroidism in dogs, particularly with extended therapy. Acute type I or type II hypersensitivities may rarely occur. Other hematologic effects (anemia, agranulocytosis) are possible but very rare. Adverse effects in cats may include anorexia, leukopenia, and anemia. In horses, transient pruritus may occur after intravenous administration.

OVERDOSE

Overdose manifestations may include gastrointestinal clinical signs (nausea, vomiting, diarrhea), CNS toxicity (depression, headache, and confusion), facial swelling, bone marrow aplasia, and elevated serum aminotransferases. Blood cell counts should be monitored closely.

DRUG INTERACTIONS

The use of antacids may decrease the bioavailability of sulfonamides if administered concomitantly. Concomitant cyclosporine may increase the risk of toxicity. The use of diuretics may increase the risk of thrombocytopenia.

Sulfonamides may displace methotrexate from plasma proteins and increase the risk of toxic effects. Sulfonamides may increase the half-life of methotrexate. Phenytoin. Sulfonamides may decrease the effectiveness of tricyclic antidepressants. Sulfonamides may prolong INR/PT times when used with warfarin.

WARNINGS

This product is for veterinary use only ; do not use on humans. Store below 25°C and away from sunlight. Keep out of reach of children.

WITHDRAWAL PERIOD: 5 days on meat and milk.

PRESENTATION: 100, 250 and 500 ml bottles.

FORMULA:

Each 100 mL contains:

Sulfamethazine: 6.66 g, Sulfamerazine: 6.66 g Sulfadiazine: 6.66 g, Sterile distilled water cbp: 100.00 ml

Active Ingredient and Formulation

• Active Components: Contains a high-potency, synergistic combination of three pharmaceutical-grade sulfonamides (such as sulfamethazine, sulfamerazine, and sulfadiazine) engineered to broaden antimicrobial coverage, disrupt bacterial folic acid synthesis, and inhibit a wide spectrum of gram-positive and gram-negative pathogens.

• Vehicle and Presentation: Formulated in a specialized, pharmaceutical-grade sterile aqueous injectable solution supplied in a secure multi-dose 500 ml glass or collapsible infusion vial designed for controlled veterinary dispensing and administration in large animals.

What Is 3 Injectable Sulfas 500ml Used For?

Primary Veterinary Indications

• Systemic Antimicrobial Therapy: Routinely utilized by equine and large-animal veterinarians and professional animal caretakers to treat acute bacterial infections affecting the respiratory, gastrointestinal, and urogenital tracts.

• Infectious Disease Control: Formulated to assist animals combating shipping fever complexes, secondary bacterial complications, foot rot, wound infections, and generalized systemic sepsis where multi-sulfonamide antibacterial intervention is critical.

• Clinical Recovery Support: Helps eliminate primary pathogenic drivers, enabling large animals to regain normal physiological function, temperature regulation, and vitality under veterinary oversight.

Administration and Dosage Considerations

Route and Dosing

• Route of Administration: Administered via slow intravenous injection or infusion, or via deep subcutaneous routes depending on clinical protocol, utilizing rigorous aseptic techniques to prevent localized irritation or microbial contamination.

• Veterinary Supervision: Exact dosage schedules, frequency of administration, and total treatment duration must be determined and monitored exclusively by a qualified veterinarian based on the individual animal’s body weight, species, clinical diagnosis, and pathogen sensitivity. Never guess or extrapolate dosages under any circumstances.

Important Safety Information

• Contraindications: Do not administer to animals with known hypersensitivity to sulfonamides, severe hepatic or renal dysfunction, blood dyscrasias, or marked dehydration where renal clearance is compromised.

• Side Effects: Prolonged or improper administration of sulfonamides can occasionally lead to crystalluria, urinary tract irritation, or hypersensitivity reactions. Adequate, constant hydration must be maintained throughout the treatment course.

• Competition and Withdrawal: Administrators and trainers must thoroughly review current governing body regulations regarding prohibited substances and mandatory withdrawal times prior to competing performance animals.

• Professional Guidance: Due to its potent pharmacological properties, use must be strictly supervised by a licensed animal health professional to mitigate potential adverse systemic effects.

Storage and Handling

• Store at controlled room temperature, protected from direct sunlight, excessive heat, and freezing temperatures.

• Inspect solution visually prior to administration; use only if the solution is clear and the container seal is intact. Maintain strict aseptic technique during administration.

• Keep securely out of reach of children, unauthorized individuals, and animals at all times.

Frequently Asked Questions

What is 3 Injectable Sulfas 500ml used for?

It is a professional veterinary multi-sulfonamide antimicrobial injection utilized to treat severe bacterial infections, respiratory disease, and systemic pathogens in large animals.

What is the volume and presentation of the product?

It is supplied in a sterile 500 ml multi-dose infusion presentation designed for controlled parenteral administration.

How is 3 Injectable Sulfas administered?

It is administered via slow intravenous injection, infusion, or deep subcutaneous routes by or under the direct supervision of a qualified veterinarian.

Is veterinary supervision required for this product?

Yes, this compound is a potent prescription antimicrobial preparation requiring professional clinical diagnosis, careful patient monitoring, and strict compliance with veterinary guidance.

What precautions should be maintained during treatment?

Treated animals must maintain continuous, adequate hydration to support renal excretion and prevent sulfonamide crystallization in the urinary tract.

Order 3 Injectable Sulfas 500ml Online

3 Injectable Sulfas 500ml is available for order through our platform subject to veterinary prescription verification and full compliance with local regulatory requirements. Ensure that valid authorization and prescription documents are prepared prior to completing your checkout. For assistance regarding stock availability, secure ordering protocols, or delivery options, please contact our customer support team.